The online edition of Proceedings of the National Academy of Sciences reports that Cincinnati University (UC) researchers have discovered that apolipoprotein A-IV (apoA-IV), a naturally produced protein that has the ability to reduce blood sugar levels and enhance insulin secretion, could be a potential target for a new diabetes treatment. ApoA-IV is a protein secreted by the small intestine in response to fat absorption. According to earlier studies, apoA-IV is elevated in individuals following gastric bypass surgery, which is linked to improved symptoms in diabetes...
Realtime Related Tweets
west virginia football black friday violence black friday violence il postino il postino online black friday deals college football scores
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.